Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience

Ann Rheum Dis. 2007 Feb;66(2):270-1. doi: 10.1136/ard.2006.058735. Epub 2006 Oct 26.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Psoriatic / pathology
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infliximab
  • Joints / pathology
  • Male
  • Middle Aged
  • Psoriasis / drug therapy
  • Skin / pathology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab